ArticleSensors (Basel, Switzerland)2025
Research and Optimization of White Blood Cell Classification Methods Based on Deep Learning and Fourier Ptychographic Microscopy.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Safety Assessment of the Ethanolic Seed Extract ofPharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
White blood cell (WBC) classification plays a crucial role in hematopathology and clinical diagnostics. However, traditional methods are constrained by limited receptive fields and insufficient utilization of contextual information, which hinders classification performance. To address these limitations, this paper proposes an enhanced WBC classification algorithm, CCE-YOLOv7, which is built upon the YOLOv7 framework. The proposed method introduces four key innovations to enhance detection accuracy and model efficiency: (1) A novel Conv2Former (Convolutional Transformer) backbone was designed to combine the local pattern extraction capability of convolutional neural networks (CNNs) with the global contextual reasoning of transformers, thereby improving the expressiveness of feature representation. (2) The CARAFE (Content-Aware ReAssembly of Features) upsampling operator was adopted to replace conventional interpolation methods, thereby enhancing the spatial resolution and semantic richness of feature maps. (3) An Efficient Multi-scale Attention (EMA) module was introduced to refine multi-scale feature fusion, enabling the model to better focus on spatially relevant features critical for WBC classification. (4) Soft-NMS (Soft Non-Maximum Suppression) was used instead of traditional NMS to better preserve true positives in densely packed or overlapping cell scenarios, thereby reducing false positives and false negatives. Experimental validation was conducted on a WBC image dataset acquired using the Fourier ptychographic microscopy (FPM) system. The proposed CCE-YOLOv7 achieved a detection accuracy of 89.3%, showing a 7.8% improvement over the baseline YOLOv7. Furthermore, CCE-YOLOv7 reduced the number of parameters by 2 million and lowered computational complexity by 5.7 GFLOPs, offering an efficient and lightweight model suitable for real-time clinical applications. To further evaluate model effectiveness, comparative experiments were conducted with YOLOv8 and YOLOv11. CCE-YOLOv7 achieved a 4.1% higher detection accuracy than YOLOv8 while reducing computational cost by 2.4 GFLOPs. Compared with the more advanced YOLOv11, CCE-YOLOv7 maintained competitive accuracy (only 0.6% lower) while using significantly fewer parameters and 4.3 GFLOPs less in computation, highlighting its superior trade-off between accuracy and efficiency. These results demonstrate that CCE-YOLOv7 provides a robust, accurate, and computationally efficient solution for automated WBC classification, with significant clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.